<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13D</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Wong Kit Christine -->
          <cik>0002097379</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Class A Ordinary shares, par value $0.0001 per share</securitiesClassTitle>
      <dateOfEvent>10/22/2025</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0002035992</issuerCIK>
        <issuerCusips>
          <issuerCusipNumber>G20528108</issuerCusipNumber>
        </issuerCusips>
        <issuerName>Charming Medical Ltd</issuerName>
        <address>
          <com:street1>Units 1803-1806, 18/F, Hang Lung Centre</com:street1>
          <com:street2>2-20 Paterson Street</com:street2>
          <com:city>Causeway Bay</com:city>
          <com:stateOrCountry>K3</com:stateOrCountry>
          <com:zipCode>0000</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>c/o Kit Wong</personName>
          <personPhoneNum>852 2116 1492</personPhoneNum>
          <personAddress>
            <com:street1>Units 1803-1806, 18/F, Hang Lung Centre</com:street1>
            <com:street2>2-20 Paterson Street</com:street2>
            <com:city>Causeway Bay</com:city>
            <com:stateOrCountry>K3</com:stateOrCountry>
            <com:zipCode>0000</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0002097379</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Kit Wong</reportingPersonName>
        <fundType>PF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>K3</citizenshipOrOrganization>
        <soleVotingPower>10350360.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>10350360.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>10350360.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>69.29</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
        <commentContent>Note to Lines 11 and 13: Kit Wong (the "Reporting Person") is an individual who beneficially owns 10,350,360 class A ordinary shares and 2,000,000 class B ordinary shares of Charming Medical Limited (the "Issuer"), representing approximately 91.65% of the aggregate voting power of the Issuer's issued and outstanding Class A and Class B Ordinary Shares. Each of the class A ordinary shares has one vote per share, while each of the class B ordinary shares has twenty (20) votes per share.

Note to Line 13: The calculation is based on 14,938,000 class A ordinary shares and 2,000,000 class B ordinary shares of the Issuer, as reported in the Issuer's prospectus on Form 424B4 filed with the U.S. Securities and Exchange Commission (the "SEC") on October 21, 2025 and the report on Form 6-K filed with the SEC on October 22, 2025.</commentContent>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Class A Ordinary shares, par value $0.0001 per share</securityTitle>
        <issuerName>Charming Medical Ltd</issuerName>
        <issuerPrincipalAddress>
          <com:street1>Units 1803-1806, 18/F, Hang Lung Centre</com:street1>
          <com:street2>2-20 Paterson Street</com:street2>
          <com:city>Causeway Bay</com:city>
          <com:stateOrCountry>K3</com:stateOrCountry>
          <com:zipCode>0000</com:zipCode>
        </issuerPrincipalAddress>
      </item1>
      <item2>
        <filingPersonName>Kit Wong</filingPersonName>
        <principalBusinessAddress>Units 1803-1806, 18/F, Hang Lung Centre, 2-20 Paterson Street, Causeway Bay, Hong Kong</principalBusinessAddress>
        <principalJob>The Reporting Person is the Chief Executive Officer, Director, and Chairman of the Board of the Issuer. The address of the Issuer is Units 1803-1806, 18/F, Hang Lung Centre, 2-20 Paterson Street, Causeway Bay, Hong Kong.</principalJob>
        <hasBeenConvicted>During the last five years, the Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).</hasBeenConvicted>
        <convictionDescription>During the last five years, the Reporting Person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.</convictionDescription>
        <citizenship>Ms. Kit Wong is a citizen of Hong Kong.</citizenship>
      </item2>
      <item3>
        <fundsSource>PF</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>The Reporting Person is pre-IPO shareholder of the Issuer. The Reporting Person acquired and continues to hold the securities with the intent to exercise control over the Issuer. Except as set forth herein, the Reporting Person does not have any present plans or proposals which relate to or would result in any of the transactions described in paragraphs (a) through (j) of this Item 4.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>Incorporated by reference to Lines 11 and 13 of the Cover Page. As of the date hereof, Ms. Kit Wong is deemed to beneficially own 10,350,360 class A ordinary shares and 2,000,000 class B ordinary shares of Charming Medical Limited (the "Issuer"), representing approximately 91.65% of the aggregate voting power of the Issuer's issued and outstanding share capital, based on 14,938,000 class A ordinary shares and 2,000,000 class B ordinary shares, as reported in the Issuer's prospectus on Form 424B4 filed with the SEC on October 21, 2025 and the report on Form 6-K filed with the SEC on October 22, 2025.</percentageOfClassSecurities>
        <numberOfShares>Incorporated by reference to Lines 7-10 of the Cover Page.</numberOfShares>
        <transactionDesc>The Reporting Person has not engaged in any transactions in the class of securities reported on that were effected during the past sixty days.</transactionDesc>
        <listOfShareholders>N/A</listOfShareholders>
        <date5PercentOwnership>N/A</date5PercentOwnership>
      </item5>
      <item6>
        <contractDescription>Except as set forth herein, the Reporting Person has no contracts, arrangements, understandings, or relationships with respect to the Issuer's securities requiring disclosure under this Item 6.</contractDescription>
      </item6>
      <item7>
        <filedExhibits>Except as set forth herein, there are no material agreements, contracts, arrangements, or understandings that require filing as exhibits under this Item 7.</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Kit Wong</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Kit Wong</signature>
          <title>Kit Wong / Shareholder</title>
          <date>03/27/2026</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>
</edgarSubmission>
